IP Library Granted Patent US 12679854
Granted Patent B2
US 12679854 · App. 17/821,321 · Granted Jul 14, 2026

Anthraquinone-functionalized polymerization initiators and their use in the manufacture of ophthalmic lenses

Inventors: Michael F. Widman (Jacksonville, FL); Ghulam Maharvi (Jacksonville, FL); Shivkumar Mahadevan (Jacksonville, FL); Azaam Alli (Jacksonville, FL); Alexander Guzman (Jacksonville, FL); Xin Wei (Irvine, CA); Minghan Chen (Jacksonville, FL)
Assignee: Johnson & Johnson Vision Care, Inc.
C07F9/535G02C7/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12679854
App. No.
17/821,321
Granted
Jul 14, 2026
Kind
B2
Abstract

Provided are compounds that may function as functionalized polymerization initiators, for instance in the manufacture of ophthalmic lenses, and to methods of such manufacture. The compounds are of formula I: wherein R 1 , R 2 , R 3 , R 4 , p, q, r, s, v, w, and X 1 are as defined herein.

Claims (45)

1 . A compound of formula I:

wherein p, q, r, and s are independently at each occurrence 0, 1, 2, 3, 4, or 5;

X 1 is a bridging group optionally containing one or more repeating segments;

v and w are independently an integer ranging from 1 to 3000;

R 1 and R 2 , when present, are independently at each occurrence alkyl, cycloalkyl, alkoxy, or halo;

R 3 and R 4 , when present, are independently at each occurrence alkyl, cycloalkyl, alkoxy, halo, or a moiety of formula II:

wherein formula II is linked to formula I via X 2 , wherein X 2 is a bridging group.

2 . The compound of claim 1 wherein p and q are 3 at each occurrence.

3 . The compound of claim 2 wherein R 1 and R 2 are independently at each occurrence alkyl.

4 . The compound of claim 1 wherein r is 0 at each occurrence and s is 0 at each occurrence.

5 . The compound of claim 1 wherein r is 1 at each occurrence and s is 0 at each occurrence.

6 . The compound of claim 5 wherein v and w are each 1 and R 3 is of formula II.

7 . The compound of claim 1 wherein X 2 , when present, comprises: one or more of alkylene, haloalkylene, amide, amine, alkyleneamine, carbamate, carboxylate (—CO 2 —), carbonyl (C═O), arylene, heteroarylene, cycloalkylene, heterocycloalkylene, alkyleneoxy, oxaalkylene, or thiaalkylene.

8 . The compound of claim 1 wherein X 1 comprises: oxaalkylene, carboxylate, -carboxylate-alkylene-, or -oxaalkylene-carbonyl-.

9 . The compound of claim 1 that is of formula I-A:

wherein X 3 is a -carboxylate-alkylene- group.

10 . The compound of claim 9 that is of formula I-A-1:

11 . The compound of claim 1 that is of formula I-B:

Wherein X 4 is a bridging group, X 5 is a bridging group, R 4 is H or methyl, T is a chain terminating group, and m is an integer ranging from 10 to 3000.

12 . The compound of claim 11 that is of formula I-B-1:

13 . The compound of claim 1 that is of formula I-C:

Wherein X 6 is a bridging group, X 7 is a bridging group, T is independently a chain terminating group or an initiator fragment.

14 . The compound of claim 13 that is of formula I-C-1:

15 . The compound of claim 1 that is of formula I-D:

wherein X 6 is a bridging group, X 7 is a bridging group, T is independently a chain terminating group or an initiator fragment, c, b, and a are integers independently ranging from 1 to 1500, and Q is derived from a hydrophilic monomer.

16 . The compound of claim 15 that is of formula I-D-1:

17 . The compound of claim 1 that is of formula I-E:

Wherein X 8 is a bridging group, and X 9 is a bridging group.

18 . The compound of claim 17 that is of formula I-E-1:

19 . The compound of claim 1 that is:

where m is an integer ranging from 10 to 3000, and T is a chain terminating group,

where m is an integer ranging from 10 to 3000 and n is an integer ranging from 1 to 100, and each T is independently a chain terminating group or an initiator fragment,

wherein a is an integer ranging from 1 to 100, b is an integer ranging from 1 to 100, c is an integer ranging from 1 to 250, T is independently a chain terminating group or an initiator fragment, and Q is derived from a hydrophilic monomer.

20 . A method for forming an ophthalmic lens, the method comprising:

(a) providing a mold assembly comprised of a base curve and a front curve, the base curve and the front curve defining and enclosing a cavity therebetween, the cavity containing a reactive monomer mixture, wherein the reactive monomer mixture comprises a monomer suitable for making the ophthalmic lens, a first polymerization initiator that is capable of being activated at a first wavelength, a first functional moiety chemically linked to the first polymerization initiator, and a second polymerization initiator that is capable of being activated by a second activation that does not substantially activate the first polymerization initiator, wherein at least one of the base curve or front curve is light transmissive;

(b) exposing one or more selective regions of the reactive monomer mixture to a source of actinic radiation at the first wavelength to thereby selectively polymerize a portion of the reactive monomer mixture, wherein the selectively polymerized portion incorporates the first functional moiety;

(c) exposing the reactive monomer mixture to the second activation to activate the second polymerization initiator and cure the reactive monomer mixture;

(d) removing the ophthalmic lens from the mold assembly; and

(e) extracting unreacted first polymerization initiator from the ophthalmic lens, wherein the first polymerization initiator having a chemically linked first functional moiety is a compound of claim 1 .

21 . A reactive monomer mixture for making an ophthalmic lens, the reactive monomer mixture comprising:

a monomer suitable for making the ophthalmic lens;

a first polymerization initiator capable of being activated at a first wavelength;

a first functional moiety chemically linked to the first polymerization initiator; and

a second polymerization initiator that is capable of being activated by a second activation that does not substantially activate the first polymerization initiator,

wherein the first polymerization initiator having a chemically linked first functional moiety is a compound of claim 1 .